Anti-inflammatory effects of statins beyond cholesterol lowering.
作者信息
Joo Seung-Jae
机构信息
Cardiology Division, Department of Internal Medicine, Jeju National University Hospital, Jeju, Korea.
出版信息
Korean Circ J. 2012 Sep;42(9):592-4. doi: 10.4070/kcj.2012.42.9.592. Epub 2012 Sep 27.
Abstract
摘要
相似文献
1
Anti-inflammatory effects of statins beyond cholesterol lowering.他汀类药物降低胆固醇之外的抗炎作用。
Korean Circ J. 2012 Sep;42(9):592-4. doi: 10.4070/kcj.2012.42.9.592. Epub 2012 Sep 27.
2
Nonlipid-lowering effects of statins.他汀类药物的非降脂作用。
Curr Treat Options Cardiovasc Med. 2005 Dec;7(6):459-66. doi: 10.1007/s11936-005-0031-1.
3
Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.他汀类药物的多效性作用：证据表明其益处不仅限于降低 LDL 胆固醇。
Am J Cardiovasc Drugs. 2010;10 Suppl 1:10-7. doi: 10.2165/1158822-S0-000000000-00000.
4
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.他汀类药物与心血管疾病：从降低胆固醇到多效性
Curr Pharm Des. 2009;15(5):467-78. doi: 10.2174/138161209787315684.
5
Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin.瑞舒伐他汀在载脂蛋白E*3-莱顿转基因小鼠中，除了降低血浆胆固醇的作用外，还能独立减少动脉粥样硬化的发展：瑞舒伐他汀抗炎作用的证据。
Circulation. 2003 Sep 16;108(11):1368-74. doi: 10.1161/01.CIR.0000086460.55494.AF. Epub 2003 Aug 25.
6
Modulation of the inflammatory process by statins.他汀类药物对炎症过程的调节作用。
Timely Top Med Cardiovasc Dis. 2005 Mar 1;9:E3.
7
Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.他汀类药物的多效性作用：除降低 LDL 胆固醇之外的获益证据。
Am J Cardiovasc Drugs. 2010;10 Suppl 1:3-9. doi: 10.2165/1153644-S0-000000000-00000.
8
Statins Promote Interleukin-1β-Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol.他汀类药物通过降低异戊烯化而非胆固醇促进白细胞介素-1β依赖性脂肪细胞胰岛素抵抗。
Diabetes. 2019 Jul;68(7):1441-1448. doi: 10.2337/db18-0999. Epub 2019 Apr 22.
9
Modulation of the inflammatory process by statins.他汀类药物对炎症过程的调节作用。
Drugs Today (Barc). 2003 Feb;39(2):137-43. doi: 10.1358/dot.2003.39.2.740209.
10
Statins in the 21st century: end of the simple story?21世纪的他汀类药物：简单故事的终结？
Expert Opin Investig Drugs. 2001 Sep;10(9):1755-66. doi: 10.1517/13543784.10.9.1755.
引用本文的文献
1
Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy.他汀类药物治疗的2型糖尿病患者血脂谱、肝酶、肌酸激酶和乳酸脱氢酶的比较
Diabetes Metab Syndr Obes. 2020 Mar 18;13:763-773. doi: 10.2147/DMSO.S234382. eCollection 2020.
2
Differential metabolic actions of specific statins: clinical and therapeutic considerations.特定他汀类药物的差异化代谢作用：临床和治疗方面的考虑。
Antioxid Redox Signal. 2014 Mar 10;20(8):1286-99. doi: 10.1089/ars.2013.5531. Epub 2013 Sep 24.
本文引用的文献
1
The effect of doubling the statin dose on pro-inflammatory cytokine in patients with triple-vessel coronary artery disease.他汀类药物剂量加倍对三血管病变冠心病患者促炎细胞因子的影响。
Korean Circ J. 2012 Sep;42(9):595-9. doi: 10.4070/kcj.2012.42.9.595. Epub 2012 Sep 27.
2
Inflammation and the development of atherosclerosis.炎症与动脉粥样硬化的发生。
J Atheroscler Thromb. 2011;18(5):351-8. doi: 10.5551/jat.7591. Epub 2011 Mar 18.
3
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).在 Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) 研究中，基线高敏 C 反应蛋白水平与罗苏伐他汀的心血管结局的关系。
Am J Cardiol. 2010 Jul 15;106(2):204-9. doi: 10.1016/j.amjcard.2010.03.018. Epub 2010 Jun 10.
4
C-reactive protein lowering with rosuvastatin in the METEOR study.METEOR 研究中瑞舒伐他汀降低 C 反应蛋白。
J Intern Med. 2010 Aug;268(2):155-61. doi: 10.1111/j.1365-2796.2010.02230.x. Epub 2010 Mar 6.
5
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.C-反应蛋白浓度与冠心病、卒中和死亡风险的关系：一项个体参与者荟萃分析。
Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22.
6
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.瑞舒伐他汀起始治疗后C反应蛋白、低密度脂蛋白胆固醇降低及心血管事件发生率：JUPITER试验的前瞻性研究
Lancet. 2009 Apr 4;373(9670):1175-82. doi: 10.1016/S0140-6736(09)60447-5. Epub 2009 Mar 28.
7
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
8
The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis.他汀类药物对内皮功能、血管炎症、免疫调节和血栓形成的多效性作用。
Atherosclerosis. 2009 Apr;203(2):325-30. doi: 10.1016/j.atherosclerosis.2008.08.022. Epub 2008 Sep 2.
9
Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis.降胆固醇治疗对C反应蛋白的低密度脂蛋白依赖性和非依赖性影响：一项荟萃分析。
J Am Coll Cardiol. 2007 May 22;49(20):2003-9. doi: 10.1016/j.jacc.2007.01.083. Epub 2007 May 4.
10
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.比较强化他汀治疗与中等强度他汀治疗的心血管结局试验的荟萃分析。
J Am Coll Cardiol. 2006 Aug 1;48(3):438-45. doi: 10.1016/j.jacc.2006.04.070. Epub 2006 Jul 12.
Zotero 插件